In this week’s industry news round-up we set the focus on Alzheimer’s disease (AD), with another clinical trial termination announced and a new framework for defining AD.
In this week’s round-up, we cover the latest industry news from depression and Parkinson’s disease. Find out more about our selection of the highlights this week.
Naomi Hartopp (KCL) reports on the Early Careers Day at the ARUK Conference 2018.
As more Alzheimer’s research programs are terminated, check out our highlights from the latest neuroscience and neurology industry headlines.
Genetics are a risk factor for developing dementia due to Alzheimer’s disease and now several Alzheimer’s prevention trials are focused on individuals, who based on their age and genetic profile, are at high risk for developing the disease.
From novel biomarkers, to the potential use of the Zika virus as a tumor treatment, read our round-up of the biggest neuro-oncology news from the last year as we mark World Cancer Day.
From clinical trial results to major policy change announcements, here we present an overview of the latest industry news from the biggest players in neuroscience and neurology